Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Identifying and addressing unmet therapeutic needs in MS.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Altered serotonin transporter availability in patients with multiple sclerosis.
Deficient phosphorylation of stat1 in leukocytes identifies neutralizing antibodies in multiple sclerosis patients treated with interferon-Beta.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
Targeting calpain-mediated proteolysis and peptide signaling as a strategy to reduce injury in multiple sclerosis.
IL-27 Limits Central Nervous System Viral Clearance by Promoting IL-10 and Enhances Demyelination.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Hepatocyte Growth Factor Limits Autoimmune Neuroinflammation via Glucocorticoid-Induced Leucine Zipper Expression in Dendritic Cells.
Safety of disease-modifying drugs for multiple sclerosis in pregnancy: current challenges and future considerations for effective pharmacovigilance.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Learning to fly with broken wings - forcing a reappraisal of time and space.
The effect of group psycho-education program on the burden of family caregivers with multiple sclerosis patients in Isfahan in 2013-2014.
Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Chronic inflammatory demyelinating polyradiculoneuropathy: update on clinical features, phenotypes and treatment options.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Primary CNS lymphoma masquerading as tumefactive demyelination.
Prognostic Indicators of Acute Transverse Myelitis in 39 Children.
T cells from autoimmune patients display reduced sensitivity to immunoregulation by mesenchymal stem cells: Role of IL-2.
Vitamin D immunomodulatory potential in multiple sclerosis.
The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.
PKA Reduces the Rat and Human KCa3.1 Current, CaM Binding, and Ca2+ Signaling, Which Requires Ser332/334 in the CaM-Binding C Terminus.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.
TREM2 regulates microglial cell activation in response to demyelination in vivo.
Pages
« first
‹ previous
…
375
376
377
378
379
380
381
382
383
…
next ›
last »